| titleOfInvention |
1414 molecules, 1481 molecules, 1553 molecules, 34021 molecules, 1720 molecules, 1683 molecules, 1552 molecules, 1682 molecules, 1682 molecules, 1675 molecules, 12825 molecules, 9952 molecules, 5816 molecules, 12002 molecules, 1611 molecules, 1371 molecules, 14324 molecules, 126 molecules Methods and compositions for treating AIDS and HIV related disorders using 270 molecules, 312 molecules, 167 molecules, 326 molecules, 18926 molecules, 6747 molecules, 1793 molecules, 1784 molecules or 2045 molecules |
| abstract |
The present invention relates to methods for diagnosis and treatment of AIDS or HIV-related disorders. In particular, the present invention operates in tissues associated with AISD or HIV-related disorders as compared to expression in normal conditions, or non-AIDS or non-HIV related disease states, and / or in relation to AIDS or HIV-related disorders 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 12002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, The differential expression of the 1793, 1784, and 2045 genes is identified. The present invention describes methods for diagnostic evaluation and prognosis of various HIV-related disorders, and methods for the identification of subjects who are predisposed to such conditions. |